Beyond the presence of PD-L1 in tumor cells in the EBV+ cases, all 12 evaluated EBV+ GCs possessed PD-L1+ immune cells, a finding found in only five out of 10 (50%) EBV negative GCs. Here, CD274 is linked to neoplasm.